171 related articles for article (PubMed ID: 30826719)
1. Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism.
Lange N; Méan M; Stalder O; Limacher A; Tritschler T; Rodondi N; Aujesky D
Thromb Res; 2019 May; 177():10-16. PubMed ID: 30826719
[TBL] [Abstract][Full Text] [Related]
2. Association between insurance status, anticoagulation quality, and clinical outcomes in patients with acute venous thromboembolism.
Zumbrunn B; Stalder O; Méan M; Limacher A; Tritschler T; Rodondi N; Aujesky D
Thromb Res; 2019 Jan; 173():124-130. PubMed ID: 30529390
[TBL] [Abstract][Full Text] [Related]
3. Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.
Hofmann E; Faller N; Limacher A; Méan M; Tritschler T; Rodondi N; Aujesky D
PLoS One; 2016; 11(9):e0162108. PubMed ID: 27606617
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
Nagler M; Angelillo-Scherrer A; Méan M; Limacher A; Abbal C; Righini M; Beer JH; Osterwalder J; Frauchiger B; Aschwanden M; Matter CM; Kucher N; Cornuz J; Banyai M; Husmann M; Staub D; Mazzolai L; Hugli O; Rodondi N; Aujesky D
J Thromb Haemost; 2017 Nov; 15(11):2165-2175. PubMed ID: 28834238
[TBL] [Abstract][Full Text] [Related]
5. Bleeding Risk in Elderly Patients with Venous Thromboembolism Who Would Have Been Excluded from Anticoagulation Trials.
Schenker C; Stalder O; Méan M; Tritschler T; Righini M; Rodondi N; Aujesky D
Thromb Haemost; 2023 Apr; 123(4):427-437. PubMed ID: 36649737
[TBL] [Abstract][Full Text] [Related]
6. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D
Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.
Leiss W; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Angelillo-Scherrer A; Cornuz J; Banyai M; Lämmle B; Husmann M; Egloff M; Aschwanden M; Rodondi N; Aujesky D
J Gen Intern Med; 2015 Jan; 30(1):17-24. PubMed ID: 25143224
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients.
Mearns ES; Kohn CG; Song JS; Hawthorne J; Meng J; White CM; Raut MK; Schein JR; Coleman CI
Thromb Res; 2014 Aug; 134(2):310-9. PubMed ID: 24935672
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in the elderly: A narrative review.
Tritschler T; Aujesky D
Thromb Res; 2017 Jul; 155():140-147. PubMed ID: 28550759
[TBL] [Abstract][Full Text] [Related]
12. A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
Schnegg-Kaufmann A; Calzavarini S; Limacher A; Mean M; Righini M; Staub D; Beer JH; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Husmann M; Banyai M; Aschwanden M; Mazzolai L; Hugli O; Nagler M; Daskalakis M; Rodondi N; Aujesky D; Angelillo-Scherrer A
J Thromb Haemost; 2019 Feb; 17(2):306-318. PubMed ID: 30570809
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study.
Insam C; Méan M; Limacher A; Angelillo-Scherrer A; Aschwanden M; Banyai M; Beer JH; Bounameaux H; Egloff M; Frauchiger B; Husmann M; Kucher N; Lämmle B; Matter C; Osterwalder J; Righini M; Staub D; Rodondi N; Aujesky D
PLoS One; 2016; 11(2):e0148348. PubMed ID: 26906217
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
17. SAMe-TT
Kataruka A; Kong X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Krol GD; Kaatz S; McNamara MW; Froehlich JB; Barnes GD
Vasc Med; 2017 Jun; 22(3):197-203. PubMed ID: 28145152
[TBL] [Abstract][Full Text] [Related]
18. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
Reiner MF; Stivala S; Limacher A; Bonetti NR; Méan M; Egloff M; Rodondi N; Aujesky D; von Schacky C; Lüscher TF; Camici GG; Beer JH
J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
[TBL] [Abstract][Full Text] [Related]
20. Risk of falls and bleeding in elderly patients with acute venous thromboembolism.
Kämpfen P; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Cornuz J; Banyai M; Egloff M; Aschwanden M; Bounameaux H; Rodondi N; Aujesky D
J Intern Med; 2014 Oct; 276(4):378-86. PubMed ID: 24645727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
